Developer docs
API playgroundTry for free, no card

Search company profiles

Aurora Diagnostics

Full company profile

uuid000cavp

Namestring
Aurora Diagnostics
Legal namestring
Sonic Healthcare USA
Websiteurl
auroradx.com
Company typeenum
Private
Founded yearint
2006
Descriptiontext

Aurora Diagnostics, now operating as the Anatomic Pathology division of Sonic Healthcare USA, is a U.S. anatomic pathology services provider founded in 2006. The company delivers diagnostic pathology services through a national network of clinical laboratories and pathology practices, employing 380+ pathologists organized under a Medical Leadership model that emphasizes subspecialty expertise. Core service offerings include Anatomic Pathology (surgical pathology, cytopathology, clinical pathology consultations), Dermatopathology (skin disease diagnostics including melanoma and carcinoma evaluation), Molecular Diagnostics (genomic and genetic analyses), and Hospital Services. Featured testing solutions extend into higher-value specialty areas: ThyroSeq for thyroid cancer molecular testing, AuraSeq for genomic sequencing, Women's Health panels, Companion Diagnostics for therapeutic biomarker identification, and COVID-19 testing. Clinician workflow is supported through the ConnectDX digital platform, specimen submission infrastructure, and a searchable online Test Menu, while patient-facing resources include education materials (English and Spanish) and cost savings programs.

The company's go-to-market is sales-led, targeting hospitals, healthcare facilities, and clinicians through direct enterprise relationships, with a secondary patient-facing channel for billing, education, and financial assistance. Revenue is generated through professional services billing for diagnostic testing to healthcare providers and patients. The company pursues a vertical segmentation approach within healthcare, addressing diagnostic testing, pathology consultation, molecular diagnostics, and hospital pathology service needs. Following a period of aggressive inorganic growth (seven acquisitions completed between 2015 and 2017), the business was integrated into Sonic Healthcare Limited (ASX:SHL), an Australian publicly listed diagnostic conglomerate, as the U.S. Anatomic Pathology division headquartered in Dallas, TX.

Technology differentiation centers on subspecialty pathologist expertise, proprietary featured testing solutions (AuraSeq, ThyroSeq), and the Medical Leadership organizational model rather than platform technology. No AI/ML capabilities, APIs, or software product lines are disclosed; the digital footprint is limited to clinician workflow tooling (ConnectDX) and patient resource portals. The company serves millions of patients annually across the United States, with operations confined to the domestic market.

Short descriptiontext

Aurora Diagnostics operates as Sonic Healthcare USA's Anatomic Pathology division, providing diagnostic pathology, dermatopathology, molecular diagnostics, and hospital services through 380+ pathologists across a national network of clinical laboratories serving hospitals, clinicians, and patients in the United States.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersPalm Beach Gardens, United States
HQ citystring
Palm Beach Gardens
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
anatomic pathology services, diagnostic laboratory testing, molecular diagnostics, dermatopathology services, hospital pathology services
Industry4 codes
PRIMARYHLAFAMAA
Anatomic Pathology (Histopathology & Cytopathology)
SECONDARYHLAKACAC
Dermatopathology
SECONDARYHLACAMAJ
Pathology Reporting, Synoptic Templates & Cancer Registry Interfaces
Healthcare & Life Sciences/Digital Health & Health IT/Laboratory Information Systems (LIS/LIMS) & Pathology Informatics
SECONDARYHLAFAKAN
Independent Diagnostic Testing Facilities (IDTFs) & Multi-Specialty Diagnostic Centers
NAICS code2 codes
  • Medical and Diagnostic Laboratories62151
  • Medical Laboratories621511
SIC code1 code
  • Services-Medical Laboratories8071
Product category
Diagnostic Pathology Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Diagnostic Pathology Services
TypeProfessional Services
Description

Provides anatomical pathology, dermatopathology, molecular diagnostics, and hospital services to healthcare providers. Revenue generated through diagnostic testing services billed to healthcare facilities, hospitals, and patients.

sonichealthcareusa.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Aurora Diagnostics (now Sonic Healthcare USA Anatomical Pathology) provides anatomic pathology, dermatopathology, molecular diagnostics, and hospital pathology services through a national network of clinical laboratories. The company offers specialized testing solutions including AuraSeq genomic sequencing, ThyroSeq thyroid cancer testing, Women's Health diagnostics, Companion Diagnostics, and COVID-19 testing. Its 380+ pathologists deliver diagnostic, prognostic, and therapeutic testing services to healthcare facilities, hospitals, and clinicians across the United States.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Millions of patients served through network of pathology practices
Product overview1 text field

Aurora Diagnostics operates as a division of Sonic Healthcare USA, providing a comprehensive anatomical pathology service platform with a network of 380+ pathologists serving millions of patients. The core offering centers on Anatomic Pathology services supplemented by specialized subspecialty areas including Dermatopathology and Molecular Diagnostics. The portfolio includes featured testing solutions such as AuraSeq (genomic sequencing), ThyroSeq (thyroid cancer testing), Women's Health panels, Companion Diagnostics, and COVID-19 testing. Supporting clinician workflow through ConnectDX digital platform and a comprehensive online Test Menu, the company delivers integrated diagnostic services to both healthcare providers and patients through hospital-based and outpatient settings across the United States.

Product and service9 records
1Anatomic Pathology
CategoryDiagnostic Service
Description

Comprehensive diagnostic pathology services providing assessment of tissue samples for disease diagnosis, including surgical pathology, cytopathology, and clinical pathology consultations, for healthcare providers and clinicians.

2Dermatopathology
CategoryDiagnostic Service
Description

Specialized pathology services focused on skin diseases, providing diagnostic evaluation of skin biopsies and specimens for conditions including melanoma, basal cell carcinoma, and squamous cell carcinoma, for clinicians and dermatology practices.

3Molecular Diagnostics
CategoryDiagnostic Service
Description

Advanced molecular testing services including genetic and genomic analyses for disease detection, diagnosis, and treatment guidance for healthcare providers.

4Hospital Pathology Services
CategoryDiagnostic Service
Description

Comprehensive pathology services designed for hospital settings, supporting integrated patient care with rapid and accurate diagnostic results for hospitals and inpatient care teams.

5AuraSeq Genomic Sequencing
CategoryFeatured Testing Solution
Description

Advanced genomic sequencing testing solution for precision medicine applications, offered to clinicians through Sonic Healthcare USA Anatomic Pathology.

6ThyroSeq Thyroid Cancer Testing
CategoryFeatured Testing Solution
Description

Specialized thyroid cancer molecular testing solution for improved diagnosis and treatment planning of thyroid nodules, available through Sonic Healthcare USA Anatomic Pathology.

7Women's Health Diagnostic Testing
CategoryFeatured Testing Solution
Description

Comprehensive diagnostic testing panel focused on women's health conditions including reproductive health and gynecologic conditions, offered to clinicians and patients.

8Companion Diagnostics
CategoryFeatured Testing Solution
Description

Diagnostic tests designed to identify biomarkers that predict patient response to specific therapeutic treatments, supporting personalized medicine for clinicians and oncologists.

9COVID-19 Diagnostic Testing
CategoryFeatured Testing Solution
Description

Diagnostic testing services for detection of SARS-CoV-2 infection, supporting patient diagnosis, management, and public health response for healthcare providers and patients.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
1ThyroSeq
Strategic tierFeaturedTypeTechnology or Integration
Description

ThyroSeq is featured as a testing solution on the Sonic Healthcare USA Anatomic Pathology platform, indicating a partnership or integration for thyroid cancer diagnostic testing services.

sonichealthcareusa.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Sonic Research Network provides research capabilities for the pathology network, supporting clinical research initiatives and advancing diagnostic medicine through collaborative research efforts.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Largest U.S. clinical laboratory and diagnostics company offering anatomic pathology, molecular diagnostics, and hospital/reference lab services. Directly comparable in customer base (hospitals, clinicians) and core service lines to Aurora Diagnostics.

TypeDirect peer
Description

Major U.S. diagnostics provider with extensive anatomic pathology, molecular, and specialty testing offerings. Closely comparable in scope, scale of pathologist network, and hospital/health system customer focus.

TypeDirect peer
Description

Specialized oncology and anatomic pathology lab with strong presence in molecular and hematopathology. Comparable specialty-testing positioning, particularly in oncology diagnostics and hospital channel sales.

TypeBroad incumbent
Description

Australian parent of Aurora Diagnostics; one of the world's largest diagnostics companies with global anatomic pathology operations. Comparable because it is the parent and operates the same pathology service model across multiple geographies.

TypeDirect peer
Description

U.S. full-service clinical and anatomic pathology laboratory serving hospitals, clinicians, and patients. Directly comparable in service mix (anatomic pathology, molecular, women's health) and hospital channel focus.

TypeEmerging player
Description

Specialized molecular diagnostics company focused on oncology liquid biopsy and companion diagnostics. Comparable in molecular/companion diagnostics offerings (e.g., AuraSeq, Companion Diagnostics at Aurora) but narrower oncology focus.

TypeEmerging player
Description

Specialized molecular profiling and companion diagnostics company serving oncologists and biopharma. Comparable in advanced genomic sequencing and companion diagnostic capabilities overlapping with Aurora's molecular/precision medicine tests.

TypeEmerging player
Description

Specialty molecular diagnostics and AI-driven pathology company offering comprehensive tumor profiling and companion diagnostics. Overlaps with Aurora's molecular diagnostics and companion diagnostics product lines.

TypeEmerging player
Description

AI-driven digital pathology company developing diagnostic and biomarker tools for anatomic pathology. Comparable as a technology-enabled pathology player, though primarily a technology partner rather than a full-service lab competitor.

TypeEmerging player
Description

Diagnostics company with Cologuard and Oncotype DX products spanning molecular diagnostics and oncology. Comparable in molecular diagnostics and companion diagnostic offerings relevant to Aurora's precision medicine portfolio.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A7 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Aurora Diagnostics

Diagnostic Pathology Servicesauroradx.com

Aurora Diagnostics operates as Sonic Healthcare USA's Anatomic Pathology division, providing diagnostic pathology, dermatopathology, molecular diagnostics, and hospital services through 380+ pathologists across a national network of clinical laboratories serving hospitals, clinicians, and patients in the United States.

What Aurora Diagnostics does

Aurora Diagnostics, now operating as the Anatomic Pathology division of Sonic Healthcare USA, is a U.S. anatomic pathology services provider founded in 2006. The company delivers diagnostic pathology services through a national network of clinical laboratories and pathology practices, employing 380+ pathologists organized under a Medical Leadership model that emphasizes subspecialty expertise. Core service offerings include Anatomic Pathology (surgical pathology, cytopathology, clinical pathology consultations), Dermatopathology (skin disease diagnostics including melanoma and carcinoma evaluation), Molecular Diagnostics (genomic and genetic analyses), and Hospital Services. Featured testing solutions extend into higher-value specialty areas: ThyroSeq for thyroid cancer molecular testing, AuraSeq for genomic sequencing, Women's Health panels, Companion Diagnostics for therapeutic biomarker identification, and COVID-19 testing. Clinician workflow is supported through the ConnectDX digital platform, specimen submission infrastructure, and a searchable online Test Menu, while patient-facing resources include education materials (English and Spanish) and cost savings programs.

The company's go-to-market is sales-led, targeting hospitals, healthcare facilities, and clinicians through direct enterprise relationships, with a secondary patient-facing channel for billing, education, and financial assistance. Revenue is generated through professional services billing for diagnostic testing to healthcare providers and patients. The company pursues a vertical segmentation approach within healthcare, addressing diagnostic testing, pathology consultation, molecular diagnostics, and hospital pathology service needs. Following a period of aggressive inorganic growth (seven acquisitions completed between 2015 and 2017), the business was integrated into Sonic Healthcare Limited (ASX:SHL), an Australian publicly listed diagnostic conglomerate, as the U.S. Anatomic Pathology division headquartered in Dallas, TX.

Technology differentiation centers on subspecialty pathologist expertise, proprietary featured testing solutions (AuraSeq, ThyroSeq), and the Medical Leadership organizational model rather than platform technology. No AI/ML capabilities, APIs, or software product lines are disclosed; the digital footprint is limited to clinician workflow tooling (ConnectDX) and patient resource portals. The company serves millions of patients annually across the United States, with operations confined to the domestic market.

Aurora Diagnostics firmographics

Firmographics
Name
Aurora Diagnostics
Legal name
Sonic Healthcare USA
Website
https://auroradx.com
Company type
Private
Founded year
2006
Operating status
Operating
Headcount range
101–250 employees
Short description
Aurora Diagnostics operates as Sonic Healthcare USA's Anatomic Pathology division, providing diagnostic pathology, dermatopathology, molecular diagnostics, and hospital services through 380+ pathologists across a national network of clinical laboratories serving hospitals, clinicians, and patients in the United States.
Ownership category
akta.pro rank

Aurora Diagnostics industry classification

Industry
Product category
Diagnostic Pathology Services
NAICS
Medical and Diagnostic Laboratories (62151), Medical Laboratories (621511)
SIC
Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLAFAMAA
Anatomic Pathology (Histopathology & Cytopathology)
SECONDARYHLAKACAC
Dermatopathology
SECONDARYHLACAMAJ
Pathology Reporting, Synoptic Templates & Cancer Registry Interfaces
Healthcare & Life Sciences/Digital Health & Health IT/Laboratory Information Systems (LIS/LIMS) & Pathology Informatics
SECONDARYHLAFAKAN
Independent Diagnostic Testing Facilities (IDTFs) & Multi-Specialty Diagnostic Centers

Keywords

  • Anatomic pathology services
  • Diagnostic laboratory testing
  • Molecular diagnostics
  • Dermatopathology services
  • Hospital pathology services

Where Aurora Diagnostics is headquartered

Location

Headquarters

HQ city
Palm Beach Gardens
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Aurora Diagnostics business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Diagnostic Pathology Services: Provides anatomical pathology, dermatopathology, molecular diagnostics, and hospital services to healthcare providers. Revenue generated through diagnostic testing services billed to healthcare facilities, hospitals, and patients.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Aurora Diagnostics product offering

Product offering

Core offering

Aurora Diagnostics (now Sonic Healthcare USA Anatomical Pathology) provides anatomic pathology, dermatopathology, molecular diagnostics, and hospital pathology services through a national network of clinical laboratories. The company offers specialized testing solutions including AuraSeq genomic sequencing, ThyroSeq thyroid cancer testing, Women's Health diagnostics, Companion Diagnostics, and COVID-19 testing. Its 380+ pathologists deliver diagnostic, prognostic, and therapeutic testing services to healthcare facilities, hospitals, and clinicians across the United States.

Product overview

Aurora Diagnostics operates as a division of Sonic Healthcare USA, providing a comprehensive anatomical pathology service platform with a network of 380+ pathologists serving millions of patients. The core offering centers on Anatomic Pathology services supplemented by specialized subspecialty areas including Dermatopathology and Molecular Diagnostics. The portfolio includes featured testing solutions such as AuraSeq (genomic sequencing), ThyroSeq (thyroid cancer testing), Women's Health panels, Companion Diagnostics, and COVID-19 testing. Supporting clinician workflow through ConnectDX digital platform and a comprehensive online Test Menu, the company delivers integrated diagnostic services to both healthcare providers and patients through hospital-based and outpatient settings across the United States.

Differentiator

Problem solved

Functional benefit

Products and services

  • Anatomic Pathology Comprehensive diagnostic pathology services providing assessment of tissue samples for disease diagnosis, including surgical pathology, cytopathology, and clinical pathology consultations, for healthcare providers and clinicians.
  • Dermatopathology Specialized pathology services focused on skin diseases, providing diagnostic evaluation of skin biopsies and specimens for conditions including melanoma, basal cell carcinoma, and squamous cell carcinoma, for clinicians and dermatology practices.
  • Molecular Diagnostics Advanced molecular testing services including genetic and genomic analyses for disease detection, diagnosis, and treatment guidance for healthcare providers.
  • Hospital Pathology Services Comprehensive pathology services designed for hospital settings, supporting integrated patient care with rapid and accurate diagnostic results for hospitals and inpatient care teams.
  • AuraSeq Genomic Sequencing Advanced genomic sequencing testing solution for precision medicine applications, offered to clinicians through Sonic Healthcare USA Anatomic Pathology.
  • ThyroSeq Thyroid Cancer Testing Specialized thyroid cancer molecular testing solution for improved diagnosis and treatment planning of thyroid nodules, available through Sonic Healthcare USA Anatomic Pathology.
  • Women's Health Diagnostic Testing Comprehensive diagnostic testing panel focused on women's health conditions including reproductive health and gynecologic conditions, offered to clinicians and patients.
  • Companion Diagnostics Diagnostic tests designed to identify biomarkers that predict patient response to specific therapeutic treatments, supporting personalized medicine for clinicians and oncologists.
  • COVID-19 Diagnostic Testing Diagnostic testing services for detection of SARS-CoV-2 infection, supporting patient diagnosis, management, and public health response for healthcare providers and patients.

Quantifiable outcome

  • Millions of patients served through network of pathology practices

Companies that use Aurora Diagnostics

Customer profile

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Aurora Diagnostics technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Aurora Diagnostics partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered featured and core.

  • ThyroSeqfeaturedTechnology or IntegrationThyroSeq is featured as a testing solution on the Sonic Healthcare USA Anatomic Pathology platform, indicating a partnership or integration for thyroid cancer diagnostic testing services.
  • Sonic Research NetworkcoreStrategic or Co-development PartnerSonic Research Network provides research capabilities for the pathology network, supporting clinical research initiatives and advancing diagnostic medicine through collaborative research efforts.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Aurora Diagnostics competitors and assessment

Company assessment

Direct peers

  • Quest Diagnostics: Largest U.S. clinical laboratory and diagnostics company offering anatomic pathology, molecular diagnostics, and hospital/reference lab services. Directly comparable in customer base (hospitals, clinicians) and core service lines to Aurora Diagnostics.
  • Laboratory Corporation of America (Labcorp): Major U.S. diagnostics provider with extensive anatomic pathology, molecular, and specialty testing offerings. Closely comparable in scope, scale of pathologist network, and hospital/health system customer focus.
  • NeoGenomics: Specialized oncology and anatomic pathology lab with strong presence in molecular and hematopathology. Comparable specialty-testing positioning, particularly in oncology diagnostics and hospital channel sales.
  • BioReference Laboratories (OPKO Health): U.S. full-service clinical and anatomic pathology laboratory serving hospitals, clinicians, and patients. Directly comparable in service mix (anatomic pathology, molecular, women's health) and hospital channel focus.

Broad incumbents

  • Sonic Healthcare Limited: Australian parent of Aurora Diagnostics; one of the world's largest diagnostics companies with global anatomic pathology operations. Comparable because it is the parent and operates the same pathology service model across multiple geographies.

Emerging players

  • Guardant Health: Specialized molecular diagnostics company focused on oncology liquid biopsy and companion diagnostics. Comparable in molecular/companion diagnostics offerings (e.g., AuraSeq, Companion Diagnostics at Aurora) but narrower oncology focus.
  • Foundation Medicine (Roche): Specialized molecular profiling and companion diagnostics company serving oncologists and biopharma. Comparable in advanced genomic sequencing and companion diagnostic capabilities overlapping with Aurora's molecular/precision medicine tests.
  • Caris Life Sciences: Specialty molecular diagnostics and AI-driven pathology company offering comprehensive tumor profiling and companion diagnostics. Overlaps with Aurora's molecular diagnostics and companion diagnostics product lines.
  • PathAI: AI-driven digital pathology company developing diagnostic and biomarker tools for anatomic pathology. Comparable as a technology-enabled pathology player, though primarily a technology partner rather than a full-service lab competitor.
  • Exact Sciences: Diagnostics company with Cologuard and Oncotype DX products spanning molecular diagnostics and oncology. Comparable in molecular diagnostics and companion diagnostic offerings relevant to Aurora's precision medicine portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Aurora Diagnostics social profiles

Digital presence

Aurora Diagnostics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Aurora Diagnostics leadership team

Management profile

Number of profiles

Profiles1 record

Aurora Diagnostics funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Aurora Diagnostics M&A and investment

M&A and investment

M&A7 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Aurora Diagnostics

What does Aurora Diagnostics do?

Aurora Diagnostics (now Sonic Healthcare USA Anatomical Pathology) provides anatomic pathology, dermatopathology, molecular diagnostics, and hospital pathology services through a national network of clinical laboratories. The company offers specialized testing solutions including AuraSeq genomic sequencing, ThyroSeq thyroid cancer testing, Women's Health diagnostics, Companion Diagnostics, and COVID-19 testing. Its 380+ pathologists deliver diagnostic, prognostic, and therapeutic testing services to healthcare facilities, hospitals, and clinicians across the United States.

Is Aurora Diagnostics a public or private company?

Aurora Diagnostics is a private company. It is classified as corporate owned and is currently operating.

When was Aurora Diagnostics founded?

Aurora Diagnostics was founded in 2006. It employs 101 to 250 people.

Where is Aurora Diagnostics based?

Aurora Diagnostics is headquartered in Palm Beach Gardens, United States, in the North America region.

How does Aurora Diagnostics make money?

One revenue line is on record: diagnostic Pathology Services.

Who are Aurora Diagnostics's main competitors?

Direct peers on record are Quest Diagnostics, Laboratory Corporation of America (Labcorp), NeoGenomics and BioReference Laboratories (OPKO Health). Sonic Healthcare Limited is listed as a broad incumbent. Emerging players are Guardant Health, Foundation Medicine (Roche), Caris Life Sciences, PathAI and Exact Sciences.

Does Aurora Diagnostics have an API?

No public API is recorded for Aurora Diagnostics.

What industry is Aurora Diagnostics in?

Aurora Diagnostics's product category is Diagnostic Pathology Services. Its primary akta.pro industry code is HLAFAMAA, Anatomic Pathology (Histopathology & Cytopathology), with a secondary code of HLAKACAC, Dermatopathology. Its NAICS code is 62151 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales